Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor
- PMID: 28865736
- PMCID: PMC5705461
- DOI: 10.1053/j.gastro.2017.08.045
Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor
Abstract
Background & aims: Dietary patterns affect systemic and local intestinal inflammation, which have been linked to colorectal carcinogenesis. Chronic inflammation can interfere with the adaptive immune response. We investigated whether the association of a diet that promotes intestinal inflammation with risk of colorectal carcinoma was stronger for tumors with lower lymphocytic reactions than tumors with higher lymphocytic reactions.
Methods: We collected data from the molecular pathological epidemiology databases of 2 prospective cohort studies: the Nurses' Health Study (since 1976) and the Health Professionals Follow-Up Study (since 1986). We used duplication-method time-varying Cox proportional cause-specific hazards regression to assess the association of empirical dietary inflammatory pattern (EDIP) score (derived from food frequency questionnaire data) with colorectal carcinoma subtype. Foods that contribute to high EDIP scores include red and processed meats, refined grains, carbonated beverages, and some vegetables; foods that contribute to low EDIP scores include beer, wine, coffee, tea, yellow and leafy vegetables, and fruit juice. Colorectal tissue samples were analyzed histologically for patterns of lymphocytic reactions (Crohn's-like lymphoid reaction, peritumoral lymphocytic reaction, intratumoral periglandular reaction, and tumor-infiltrating lymphocytes).
Results: During follow-up of 124,433 participants, we documented 1311 incident colon and rectal cancer cases with available tissue data. The association between the EDIP and colorectal cancer risk was significant (Ptrend = .02), and varied with degree of peritumoral lymphocytic reaction (Pheterogeneity < .001). Higher EDIP scores were associated with increased risk of colorectal cancer with an absent or low peritumoral lymphocytic reaction (highest vs lowest EDIP score quintile hazard ratio, 2.60; 95% confidence interval, 1.60-4.23; Ptrend < .001), but not risk of tumors with intermediate or high peritumoral lymphocytic reaction (Ptrend > .80).
Conclusions: In 2 prospective cohort studies, we associated inflammatory diets with a higher risk of colorectal cancer subtype that contains little or no peritumoral lymphocytic reaction. These findings suggest that diet-related inflammation might contribute to development of colorectal cancer, by suppressing the adaptive anti-tumor immune response.
Keywords: Adaptive Immune Cells; BRAF; CpG Island Methylator Phenotype; Cyclooxygenase-2.
Copyright © 2017 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Similar articles
-
Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum.Clin Gastroenterol Hepatol. 2018 Oct;16(10):1622-1631.e3. doi: 10.1016/j.cgh.2018.04.030. Epub 2018 Apr 24. Clin Gastroenterol Hepatol. 2018. PMID: 29702299 Free PMC article.
-
Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.Gastroenterology. 2016 Nov;151(5):879-892.e4. doi: 10.1053/j.gastro.2016.07.030. Epub 2016 Jul 27. Gastroenterology. 2016. PMID: 27475305 Free PMC article.
-
Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes.Gastroenterology. 2017 Jun;152(8):1944-1953.e1. doi: 10.1053/j.gastro.2017.02.015. Epub 2017 Feb 27. Gastroenterology. 2017. PMID: 28249812 Free PMC article.
-
Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.World J Gastroenterol. 2016 Jan 14;22(2):557-66. doi: 10.3748/wjg.v22.i2.557. World J Gastroenterol. 2016. PMID: 26811607 Free PMC article. Review.
-
Dietary patterns and colorectal cancer risk: Global Cancer Update Programme (CUP Global) systematic literature review.Am J Clin Nutr. 2025 May;121(5):999-1016. doi: 10.1016/j.ajcnut.2025.02.021. Epub 2025 Feb 25. Am J Clin Nutr. 2025. PMID: 40010692 Free PMC article.
Cited by
-
Association of body mass index and inflammatory dietary pattern with breast cancer pathologic and genomic immunophenotype in the nurses' health study.Breast Cancer Res. 2022 Nov 14;24(1):78. doi: 10.1186/s13058-022-01573-5. Breast Cancer Res. 2022. PMID: 36376974 Free PMC article.
-
Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology.Annu Rev Pathol. 2019 Jan 24;14:83-103. doi: 10.1146/annurev-pathmechdis-012418-012818. Epub 2018 Aug 20. Annu Rev Pathol. 2019. PMID: 30125150 Free PMC article. Review.
-
Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy.Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1917-1925. doi: 10.1158/1055-9965.EPI-19-0488. Epub 2019 Aug 28. Cancer Epidemiol Biomarkers Prev. 2019. PMID: 31462398 Free PMC article.
-
miR663a‑TTC22V1 axis inhibits colon cancer metastasis.Oncol Rep. 2019 Mar;41(3):1718-1728. doi: 10.3892/or.2019.6969. Epub 2019 Jan 16. Oncol Rep. 2019. PMID: 30664167 Free PMC article.
-
Risk Factor Profiles Differ for Cancers of Different Regions of the Colorectum.Gastroenterology. 2020 Jul;159(1):241-256.e13. doi: 10.1053/j.gastro.2020.03.054. Epub 2020 Apr 1. Gastroenterology. 2020. PMID: 32247020 Free PMC article.
References
-
- Lippitz BE. Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol. 2013;14:e218–228. - PubMed
Publication types
MeSH terms
Grants and funding
- R35 CA197735/CA/NCI NIH HHS/United States
- R01 CA118553/CA/NCI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- P30 DK043351/DK/NIDDK NIH HHS/United States
- UL1 TR001863/TR/NCATS NIH HHS/United States
- P01 CA055075/CA/NCI NIH HHS/United States
- R01 CA151993/CA/NCI NIH HHS/United States
- U01 CA167552/CA/NCI NIH HHS/United States
- R01 CA137178/CA/NCI NIH HHS/United States
- K24 DK098311/DK/NIDDK NIH HHS/United States
- R01 CA154426/CA/NCI NIH HHS/United States
- UM1 CA186107/CA/NCI NIH HHS/United States
- R01 CA169141/CA/NCI NIH HHS/United States
- K07 CA188126/CA/NCI NIH HHS/United States
- UM1 CA167552/CA/NCI NIH HHS/United States
- K99 CA207736/CA/NCI NIH HHS/United States
- P50 CA127003/CA/NCI NIH HHS/United States
- K07 CA190673/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials